20.80
price down icon1.98%   -0.42
pre-market  プレマーケット:  21.19   0.39   +1.88%
loading
前日終値:
$21.22
開ける:
$20.85
24時間の取引高:
1.10M
Relative Volume:
0.87
時価総額:
$13.21B
収益:
$2.89B
当期純損益:
$684.26M
株価収益率:
19.76
EPS:
1.0524
ネットキャッシュフロー:
$958.82M
1週間 パフォーマンス:
-6.09%
1か月 パフォーマンス:
+3.84%
6か月 パフォーマンス:
-22.47%
1年 パフォーマンス:
-28.64%
1日の値動き範囲:
Value
$20.75
$21.02
1週間の範囲:
Value
$19.89
$22.08
52週間の値動き範囲:
Value
$19.85
$31.88

Genmab Adr Stock (GMAB) Company Profile

Name
名前
Genmab Adr
Name
セクター
Healthcare (1172)
Name
電話
-
Name
住所
-
Name
職員
2,635
Name
Twitter
@Genmab
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
GMAB's Discussions on Twitter

GMAB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GMAB
Genmab Adr
20.80 13.21B 2.89B 684.26M 958.82M 1.0524
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.00 108.68B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
681.58 74.90B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
640.52 38.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
246.27 31.76B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
111.93 26.83B 3.30B -501.07M 1.03B -2.1146

Genmab Adr Stock (GMAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-08 開始されました Redburn Atlantic Buy
2024-09-04 再開されました Morgan Stanley Equal-Weight
2024-08-20 ダウングレード JP Morgan Overweight → Neutral
2024-07-15 アップグレード RBC Capital Mkts Sector Perform → Outperform
2024-02-23 アップグレード BMO Capital Markets Market Perform → Outperform
2024-01-22 ダウングレード Citigroup Neutral → Sell
2023-12-06 アップグレード UBS Neutral → Buy
2023-11-10 アップグレード Deutsche Bank Hold → Buy
2023-11-08 アップグレード DNB Markets Sell → Buy
2023-10-18 開始されました Exane BNP Paribas Underperform
2023-09-06 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2023-08-24 開始されました BTIG Research Buy
2023-07-14 開始されました HSBC Securities Buy
2023-05-31 開始されました UBS Neutral
2023-05-12 開始されました Morgan Stanley Underweight
2022-12-20 ダウングレード Citigroup Buy → Neutral
2022-11-14 開始されました William Blair Mkt Perform
2022-11-11 ダウングレード Deutsche Bank Buy → Hold
2022-06-24 開始されました BMO Capital Markets Market Perform
2022-05-02 開始されました Cowen Market Perform
2022-03-16 アップグレード UBS Neutral → Buy
2022-01-31 アップグレード H.C. Wainwright Neutral → Buy
2022-01-03 ダウングレード Guggenheim Buy → Neutral
2021-12-01 開始されました Berenberg Sell
2021-09-16 ダウングレード Jefferies Buy → Hold
2021-09-07 ダウングレード Morgan Stanley Equal-Weight → Underweight
2021-08-24 ダウングレード H.C. Wainwright Buy → Neutral
2021-04-20 開始されました Deutsche Bank Buy
2021-01-19 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-09-23 ダウングレード Bryan Garnier Neutral → Sell
2020-09-08 開始されました SVB Leerink Mkt Perform
2020-06-25 ダウングレード Credit Suisse Outperform → Neutral
2020-04-23 開始されました Credit Suisse Outperform
2020-02-24 繰り返されました H.C. Wainwright Buy
2020-01-13 開始されました SunTrust Buy
2019-12-12 ダウングレード Deutsche Bank Buy → Hold
2019-09-13 アップグレード BofA/Merrill Neutral → Buy
2019-09-12 アップグレード JP Morgan Neutral → Overweight
2019-08-12 開始されました Guggenheim Buy
2019-08-12 開始されました Morgan Stanley Overweight
2019-08-12 開始されました RBC Capital Mkts Outperform
すべてを表示

Genmab Adr (GMAB) 最新ニュース

pulisher
Jan 17, 2025

GMAB vs. QGEN: Which Stock Is the Better Value Option? - MSN

Jan 17, 2025
pulisher
Jan 14, 2025

Genmab (GMAB) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Jan 14, 2025
pulisher
Jan 14, 2025

Are Investors Undervaluing Genmab (GMAB) Right Now? - Yahoo Finance

Jan 14, 2025
pulisher
Jan 03, 2025

Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.

Jan 03, 2025
pulisher
Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024
pulisher
Nov 12, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 12, 2024
pulisher
Oct 16, 2024

Is the Options Market Predicting a Spike in Genmab (GMAB) Stock? - Yahoo Finance

Oct 16, 2024
pulisher
Oct 15, 2024

Is Genmab (GMAB) Stock Undervalued Right Now? - Yahoo Finance

Oct 15, 2024
pulisher
Oct 08, 2024

GMAB or INCY: Which Is the Better Value Stock Right Now? - Yahoo Finance

Oct 08, 2024
pulisher
Oct 08, 2024

Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround - Yahoo Finance

Oct 08, 2024
pulisher
Sep 24, 2024

Market Resilience: Genmab ADR (GMAB) Finishes Weak at 24.14, Down -5.44 - The Dwinnex

Sep 24, 2024
pulisher
Sep 19, 2024

GANDHIM.APPL Share Price Today Up 13% - Equitymaster

Sep 19, 2024
pulisher
Sep 18, 2024

Glenmark Pharma Share Price Today Down 3% - Equitymaster

Sep 18, 2024
pulisher
Sep 16, 2024

Post-Trade Analysis: Genmab ADR (GMAB) Climbs 1.55, Closing at 26.90 - The Dwinnex

Sep 16, 2024
pulisher
Sep 04, 2024

Market Recap: Genmab ADR (GMAB)’s Negative Momentum, Closing at 27.41 - The Dwinnex

Sep 04, 2024
pulisher
Aug 06, 2024

All You Need to Know About Genmab (GMAB) Rating Upgrade to Strong Buy - MSN

Aug 06, 2024
pulisher
Aug 05, 2024

BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls - Yahoo Finance

Aug 05, 2024
pulisher
Aug 02, 2024

Wall Street Analysts Think Genmab (GMAB) Could Surge 45.08%: Read This Before Placing a Bet - Yahoo Finance

Aug 02, 2024
pulisher
Jul 25, 2024

GMAB vs. CSLLY: Which Stock Is the Better Value Option? - Yahoo Finance

Jul 25, 2024
pulisher
Jul 17, 2024

Wall Street Analysts Believe Genmab (GMAB) Could Rally 52.33%: Here's is How to Trade - Yahoo Finance Australia

Jul 17, 2024
pulisher
Jul 15, 2024

RBC Capital upgrades Genmab stock amid strong pipeline prospects - Investing.com

Jul 15, 2024
pulisher
Jul 09, 2024

GMAB or TECH: Which Is the Better Value Stock Right Now? - Yahoo Finance

Jul 09, 2024
pulisher
Jul 08, 2024

GMAB vs. TECH: Which Stock Is the Better Value Option? - Yahoo Finance

Jul 08, 2024
pulisher
Jun 27, 2024

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma - Yahoo Finance

Jun 27, 2024
pulisher
Apr 10, 2024

GMAB: 3 Biotech Stocks Gaining Altitude and Interest - StockNews.com

Apr 10, 2024
pulisher
Apr 03, 2024

Genmab's 'Evolution' Continues With A $1.8 Billion Deal; But Shares Slip - Investor's Business Daily

Apr 03, 2024
pulisher
Mar 01, 2024

GMAB: Bank on the Future Returns With These 3 Biotech Stocks - StockNews.com

Mar 01, 2024
pulisher
Jan 17, 2024

New Strong Buy Stocks for January 17th - Yahoo Finance

Jan 17, 2024
pulisher
Dec 12, 2023

GMAB: 3 Biotech Stocks to Boost Portfolios - StockNews.com

Dec 12, 2023
pulisher
Nov 10, 2023

GMAB: 3 Biotech Stocks to Watch in November - StockNews.com

Nov 10, 2023
pulisher
Sep 05, 2023

Zai Lab ADR surges after Seagen, Genmab release cervical cancer treatment results - MarketWatch

Sep 05, 2023
pulisher
May 19, 2023

GMAB: 2 Explosive Biotech Stocks to Own - StockNews.com

May 19, 2023
pulisher
Feb 27, 2023

Stocks Generating Improved Relative Strength: Genmab ADR - Investor's Business Daily

Feb 27, 2023
pulisher
Feb 23, 2023

Stocks Flashing Renewed Technical Strength: Ascendis Pharma ADR - Investor's Business Daily

Feb 23, 2023
pulisher
Feb 10, 2023

Moderna Stock Getting Closer To Key Technical Benchmark - Inkl

Feb 10, 2023
pulisher
Feb 06, 2023

Stock Upgrades: Legend Biotech ADR Shows Rising Relative Strength - Investor's Business Daily

Feb 06, 2023
pulisher
Jan 23, 2023

GILD or GMAB: Which Is the Better Value Stock Right Now? - Yahoo News Canada

Jan 23, 2023
pulisher
Jan 18, 2023

Ascendis Pharma ADR Scores Relative Strength Rating Upgrade; Hits Key Benchmark - Investor's Business Daily

Jan 18, 2023
pulisher
Dec 12, 2022

Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Dec 12, 2022
pulisher
Nov 29, 2022

Horizon Therapeutics Is A Stock With Rising Relative Strength - Investor's Business Daily

Nov 29, 2022
pulisher
Nov 24, 2022

Genmab's chief development officer sells shares in US - MedWatch

Nov 24, 2022
pulisher
Aug 31, 2022

Stocks To Watch: Genmab Sees Relative Strength Rating Jump To 82 - Investor's Business Daily

Aug 31, 2022
pulisher
Aug 09, 2022

Zealand Pharma to delist in US - MedWatch

Aug 09, 2022
pulisher
May 10, 2022

Should You Buy Genmab (GMAB) Ahead of Earnings? - Yahoo Finance

May 10, 2022
pulisher
Mar 29, 2021

Inside Genmab's blockbuster IPO - IR Magazine

Mar 29, 2021
pulisher
Feb 24, 2021

Pipeline of Proprietary Antibodies - flow – Deutsche Bank

Feb 24, 2021
pulisher
Jan 13, 2021

Emergent BioSolutions Sees Its Composite Rating Rise To 97 - Investor's Business Daily

Jan 13, 2021
pulisher
Jan 05, 2021

Genmab (GMAB) Begins Phase III Study on Cervical Cancer Drug - Yahoo Finance

Jan 05, 2021
pulisher
Jun 16, 2020

The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO - Benzinga

Jun 16, 2020
pulisher
Aug 19, 2019

Genmab's offering and listing in the USA - Bech-Bruun

Aug 19, 2019
pulisher
Aug 08, 2019

Genmab AS (GMAB) Stock Price, Trades & News - GuruFocus.com

Aug 08, 2019

Genmab Adr (GMAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
大文字化:     |  ボリューム (24 時間):